IOVA - CIK 0001425205
IOVANCE BIOTHERAPEUTICS, INC. has filed 1,005 documents with the SEC between 2008 and 2026. The most frequent type is insider trade (273 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2023-08-18 | 2023-08-16 |
| Quarterly report | 10-Q | 2023-08-08 | 2023-06-30 |
| Major company event | 8-K | 2023-08-08 | 2023-08-08 |
| Insider trade | 4 | 2023-07-17 | 2023-07-14 |
| Insider trade | 4 | 2023-07-17 | 2023-07-14 |
| Insider trade | 4 | 2023-07-17 | 2023-07-14 |
| Major company event | 8-K | 2023-07-13 | 2023-07-13 |
| Prospectus supplement | 424B5 | 2023-07-11 | - |
| Major company event | 8-K | 2023-07-11 | 2023-07-10 |
| Prospectus supplement | 424B5 | 2023-07-10 | - |
| Major company event | 8-K | 2023-07-10 | 2023-07-10 |
| Major company event | 8-K | 2023-07-10 | 2023-07-10 |
| Major company event | 8-K | 2023-06-16 | 2023-06-16 |
| Prospectus supplement | 424B5 | 2023-06-16 | - |
| S-3ASR | - | 2023-06-16 | - |
| Employee stock plan | S-8 | 2023-06-12 | - |
| Employee stock plan | S-8 | 2023-06-12 | - |
| Insider trade | 4 | 2023-06-08 | 2023-06-06 |
| Insider trade | 4 | 2023-06-08 | 2023-06-06 |
| Insider trade | 4 | 2023-06-08 | 2023-06-06 |
| Insider trade | 4 | 2023-06-08 | 2023-06-06 |
| Insider trade | 4 | 2023-06-08 | 2023-06-06 |
| Insider trade | 4 | 2023-06-08 | 2023-06-06 |
| Major company event | 8-K | 2023-06-06 | 2023-06-06 |
| Major company event (amended) | 8-K/A | 2023-06-02 | 2023-05-18 |
| Major company event | 8-K | 2023-05-30 | 2023-05-26 |
| Major company event | 8-K | 2023-05-18 | 2023-05-18 |
| Quarterly report | 10-Q | 2023-05-10 | 2023-03-31 |
| Employee stock plan | S-8 | 2023-05-10 | - |
| Major company event | 8-K | 2023-05-09 | 2023-05-09 |
| Annual report to shareholders | ARS | 2023-04-27 | 2022-12-31 |
| Proxy materials | DEFA14A | 2023-04-26 | - |
| Proxy statement | DEF 14A | 2023-04-26 | - |
| SEC correspondence | UPLOAD | 2023-04-25 | - |
| Major company event | 8-K | 2023-04-24 | 2023-04-18 |
| Insider trade | 4 | 2023-04-20 | 2023-04-18 |
| New insider ownership | 3 | 2023-04-20 | 2023-04-18 |
| PRER14A | - | 2023-04-19 | - |
| Insider trade | 4 | 2023-04-18 | 2023-04-14 |
| Insider trade | 4 | 2023-04-18 | 2023-04-14 |
| Insider trade | 4 | 2023-04-18 | 2023-04-14 |
| PRE 14A | - | 2023-04-14 | - |
| Major company event | 8-K | 2023-03-27 | 2023-03-24 |
| Major company event | 8-K | 2023-03-10 | 2023-03-10 |
| Insider trade | 4 | 2023-03-06 | 2023-03-02 |
| Insider trade | 4 | 2023-03-06 | 2023-03-02 |
| Insider trade | 4 | 2023-03-06 | 2023-03-02 |
| Insider trade | 4 | 2023-03-06 | 2023-03-02 |
| Annual report | 10-K | 2023-02-28 | 2022-12-31 |
| Major company event | 8-K | 2023-02-28 | 2023-02-28 |